DNA ploidy pattern in choroidal melanoma: Correlation with survival. A flow cytometry study on archival material

British Journal of Ophthalmology

Volumn 82, Issue 12, 1998, Pages 1433-1437

  Toti, Paolo ^a   Greco, Giuseppe ^a   Mangiavacchi, Paola ^a   Bruni, Alessandra ^a   Palmeri, Marie Louise Desirèe ^a   Luzi, Pietro ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER SURVIVAL; CHOROID MELANOMA; DIPLOIDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PLOIDY; PRIORITY JOURNAL; PROGNOSIS;

EID: 0031762910     PISSN: 00071161     EISSN: None     Source Type: Journal    
DOI: 10.1136/bjo.82.12.1433     Document Type: Article

References (28)

1. Gamel JW, McLean IW, McCurdy JB. Biological distinction between cure and time to death in 2892 patients with intraocular melanoma. Cancer 1993;71:2299-305.
2. Callender GR. Malignant melanotic tumors of the eye: a study of histologic types in 111 cases. Trans Am Acad Ophthalmol Otolaryngol 1931;36:131-42.
3. McLean IW, Foster WD, Zimmerman LE, et al. Modifications of Calender's classification of uveal melanoma of the Armed Forces Institute of Pathology. Am J Ophthalmol 1983;96:502-9.
4. McLean IW, Burnier MN, Zimmermann LE, et al. Tumors of the eye and ocular adnexa. Bethesda: AFIP Atlas of tumor pathology, third series, 1994.
5. Coleman K, Baak JPA, Van Diest PJ, et al. DNA ploidy status in 84 ocular melanomas: a study of DNA quantitation in ocular melanomas by flow cytometry and automatic and interactive static image analysis. Hum Pathol 1995;26:99-105.
6. Seddon JM, Polivogianis L, Chung-Cheng Hsiech SD, et al. Death from uveal melanomas: number of epithelioid cells and inverse SD of nucleolar area as prognostic factors. Arch Ophthalmol 1987;105:801-6.
7. Augsburger JJ, Gamel JW. Clinical prognostic factors in patients with posterior uveal malignant melanoma. Cancer 1990;66:1596-600.
8. McLean IW, Gamel JW. Prediction of metastasis of uveal melanomas: comparison of morphometric determination of nuclear size and spectrophotometric determination of DNA. Invest Ophthalmol Vis Sci 1988;29:507-11.
9. Gamel JW, McCurdy JB, McLean IW. A comparison of prognostic covariates for uveal melanoma. Invest Ophthalmol Vis Sci 1992;33:1919-22.
10. Greco G, Toti P, Motolese E, et al. Morphometric evaluation of vascularization of uveal melanoma. In: Frezzotti R, Balestrazzi E, Falco, Esente S, eds. International symposium of intraocular and epibulbar tumors. Bologna: Monduzzi, 1994:91-3.
11. Folberg R, Rummelt V, Parys-Van Ginderdeuren R, et al. The prognostic value of tumor blood vessel morphology in primary uveal melanoma. Ophthalmology 1993;100:1389-98.
12. Karlsson M, Boeryd B, Carstensen J, et al. Correlation of Ki-67 and PCNA to DNA ploidy, S-phase fraction and survival in uveal melanoma. Eur J Cancer 1996;32A:357-62.
13. Mooy CM, Vissers K, Luyten G, et al. DNA flow cytometry in uveal melanoma: the effect of pre-enucleation irradiation. Br J Ophthalmol 1995;79:174-7.
14. Mooy CM, De Jong PTVM. Prognostic parameters in uveal melanoma: a review. Surv Ophthalmol 1996;41:215-28.
15. McMillan J, Char DH, McLean IW, et al. DNA content analysis of uveal melanoma. Arch Ophthalmol 1989;107: 1278.
16. Meecham WJ, Char DH. DNA content abnormalities and prognosis in uveal melanoma. Arch Ophthalmol 1986;104: 1626-9.
17. Rennie JG, Rees RC, Parsons MA, et al. Estimation of DNA content in uveal melanomas by flow cytometry. Eye 1989;3:611-17.
18. Shapiro BE, Felberg NT, Donoso LA, et al. Flow cytometry of uveal melanomas. Cancer Biochem Biophys 1986;8:235-8.
19. Shankey TV, Rabinovitch PS, Bagwell B, et al. Guidelines for implementation of clinical DNA cytometry. Cytometry 1993;14:472-7.
20. Hedley DW, Friedlander ML, Taylor JW. Application of DNA flow cytometry to paraffin-embedded archival material for the study of aneuploidy and its clinical significance. Cytometry 1985;6:327-33.
21. Marquardt DI. An algorythm for least squares estimation of nonlinear parameters. J Soc Ind Appl Math 1963;2:431-41.
22. Luzi P, Bruni A, Mangiavacchi P, et al. Ploidy pattern and cell cycle in breast cancer as detected by image analysis and flow cytometry. Commun Clin Cytometry 1994;18:79-87.
23. Coulson PB, Thornthwaite JT, Woolley TW, et al. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer survival. Cancer Res 1987;44:4187-96.
24. Ferno M, Baldetorp B, Olsson H, et al. Flow cytometric DNA index and S-Phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncol 1992;31:157-65.
25. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet 1996;347:1222-5.
26. Cohen C, Walker BF, Solomon AR, et al. DNA ploidy and cell cycle analysis in ear malignant melanoma by flow and image cytometry. Anal Quant Cytol Histol 1992;14:81-8.
27. Kute TE, Quadri Y, Muss H, et al. Flow cytometry in node-positive breast cancer: cancer and leukemia group B protocol 8869. Cytometry 1995;22:297-306.
28. Shuttle B, Reynders MMJ, Bosman FT, et al. Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin embedded tissue. Cytometry 1995;6:26-30.